[Form 4] TD SYNNEX Corporation Insider Trading Activity

Rhea-AI Filing Summary

TD SYNNEX CFO Witt Marshall reported transactions on 08/11/2025 showing both an acquisition and a sale of 862 common shares. The filing records an acquisition at a per-share price of $57.34 and a contemporaneous sale at $146.39, leaving the reporting person with 49,777 shares beneficially owned after the sale (the filing also shows 50,639 shares following the acquisition prior to the sale). The filing discloses ownership of 9,471 employee stock options following the reported transactions and notes that the sales were made pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025.

The Form 4 includes an employee stock option entry with a conversion/exercise price of $57.34 for 862 underlying shares and describes the option vesting schedule. The report is signed on behalf of the reporting person by an attorney-in-fact on 08/12/2025.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating transactions were pre-arranged (adopted May 12, 2025)
• Complete disclosure of share counts, prices, option holdings, and vesting schedule in the Form 4

Negative

• Net decrease in direct beneficial ownership of 862 shares (from 50,639 to 49,777) following the transactions

Insights

Securities Analyst

TL;DR: Routine option-related exercise and matched sale under a pre-established 10b5-1 plan; likely neutral to market.

The filing shows the CFO exercised or otherwise acquired 862 shares at $57.34 and sold 862 shares at $146.39 on 08/11/2025, with the sale executed under a Rule 10b5-1 plan adopted May 12, 2025. Such pre-arranged plans are commonly used to avoid timing concerns around material nonpublic information. The net effect reported is a reduction in direct beneficial ownership from 50,639 to 49,777 shares; derivative holdings of 9,471 options are also reported. These are routine insider transactions and, absent other material disclosures, present a neutral informational impact for investors.

Corporate Governance Expert

TL;DR: Disclosure is transparent and notes use of a 10b5-1 plan; governance practices appear followed based on the filing.

The Form 4 documents both the exercise-related activity and a contemporaneous sale of the same number of shares and explicitly cites a Rule 10b5-1 plan adopted on May 12, 2025. The filing includes an explanation of the option vesting schedule and lists the signature of an attorney-in-fact. From a governance perspective, pre-established trading plans and clear reporting support compliance with insider trading rules. The filing contains no disclosures of unusual or unexplained transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Witt Marshall

(Last) (First) (Middle)

44201 NOBEL DRIVE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2025		M		862	A	$57.34	50,639	D
Common Stock	08/11/2025		S(1)		862	D	$146.39	49,777	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$57.34	08/11/2025		M			862	(2)	10/04/2026	Common Stock	862	$0	9,471	D

Explanation of Responses:

1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

2. This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.

	/s/ Cheryl Grant, attorney-in-fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did TD SYNNEX (SNX) CFO Witt Marshall report on Form 4?

On 08/11/2025 the filing shows an acquisition of 862 common shares at $57.34 and a sale of 862 common shares at $146.39.

Were the SNX sales made under a trading plan?

Yes. The filing states the sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025.

How many SNX shares does the reporting person own after these transactions?

The Form 4 reports 49,777 shares beneficially owned after the sale (and 50,639 after the acquisition prior to the sale).

What option holdings were disclosed for SNX?

The filing reports 9,471 employee stock options beneficially owned following the reported transactions and an option entry for 862 underlying shares with a conversion/exercise price of $57.34.

Who signed the Form 4 filing for Witt Marshall?

The filing is signed by Cheryl Grant, attorney-in-fact on 08/12/2025.